Management of Primary Immune Thrombocytopenia, 2012: A Survey of Oklahoma Hematologists-Oncologists

Blood - United States
doi 10.1182/blood.v120.21.1094.1094
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Hematology

Related search

Current Management of Primary Immune Thrombocytopenia

Advances in Therapy
MedicinePharmacology
2015English

Impact of Legislation and Public Funding on Oncofertility: A Survey of Canadian, French and Moroccan Pediatric Hematologists/Oncologists

BMC Medical Ethics
Health PolicyEthicsHealthIssuesLegal Aspects
2020English

A Blinded Study of Bone Marrow Examinations in Patients With Primary Immune Thrombocytopenia

European Journal of Haematology
MedicineHematology
2012English

Immune Thrombocytopenia

Hospital Medicine Clinics
Medicine
2017English

Variability in the Therapeutic Management of Advanced Ovarian Cancer Patients: A Five-Country Survey of Oncologists

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2017English

Primary Immune Thrombocytopenia Responding to Antithyroid Treatment in a Patient With Graves’ Disease

Annals of Hematology
MedicineHematology
2010English

Switching Thrombopoietin Receptor Agonist Treatments in Patients With Primary Immune Thrombocytopenia

Therapeutic Advances in Hematology
Hematology
2019English

Thromboembolism in Adults With Primary Immune Thrombocytopenia: A Systematic Literature Review and Meta-Analysis

European Journal of Haematology
MedicineHematology
2016English

Management of Psychosocial Distress by Oncologists

Psychiatric Services
MedicinePsychiatryMental Health
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy